VIVEX Biologics

📍 Miami, United States👥 191 employees💰 Last funded Jan 2017
Biotechnology Research🌐 vivex.com
Website LinkedIn
We are the regenerative medicine company that develops and delivers innovative allograft solutions designed to support the body’s healing and regenerative potential, ultimately improving patient outcomes and quality of life. The underpinnings of our regenerative medicine solutions technology date back 50 years to the founding of The University of Miami Tissue Bank in 1970. We experienced multiple firsts in clinical and scientific achievement leading up to 2014, when VIVEX acquired the University of Miami Tissue Bank. This acquisition streamlined our strategic plan to focus on new regenerative medicine solutions, research and development, expansion of manufacturing capabilities, and sales and marketing efforts.
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2011–2017 · investors recorded per year
201112013120171
Recent (last 2y)Earlier
Frequently asked questions
Who invested in VIVEX Biologics?
VIVEX Biologics has 3 investors on record on gritt.io.
When did VIVEX Biologics last raise funding?
The most recent investment in VIVEX Biologics recorded on gritt.io was in January 2017.
What industry is VIVEX Biologics in?
VIVEX Biologics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is VIVEX Biologics based?
VIVEX Biologics is headquartered in Miami, United States.